Psilocybin-Assisted Therapy Archives

2 minute read

Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials

August 23, 8:09 PM

Starting this October, scientists at Imperial College London’s (ICL) Centre for Psychedelic Research will assess psilocybin-assisted therapy for gambling addiction, noted Psychedelic Spotlight.

FLHLF

2 minute read

Trial Gives Cancer Patients 18 Months Of Robust Benefits After One Psilocybin Session

By Lara Goldstein

May 26, 6:23 PM

Positive long-term follow-up data from Sunstone Therapies’ investigator-initiated Phase 2 study assessing COMPASS Pathways’ (NASDAQ: CMPS) synthetic psilocybin COMP360 paired with psychological support in cancer patients with Major Depressive Disorder (MDD) is out.

CMPS

1 minute read

Canadian Psychedelics Company And Nonprofit Team Up To Accelerate Access And Product Launch

By Lara Goldstein

May 18, 3:12 PM

Health-Canada licensed psychedelics biotech Lucy Scientific Discovery (NASDAQ: LSDI) and not-for-profit psilocybin advocate organization TheraPs

LSDI

2 minute read

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism

By Lara Goldstein

April 20, 9:02 AM

The partnership between contract research organization KGK Sciences Inc. and Nova Mentis Life Science Corp. (OTC: NMLSF) has started <

NMLSF

2 minute read

Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder

By Lara Goldstein

April 14, 7:04 PM

Results from an advanced clinical trial assessing psilocybin-assisted therapy for patients with cancer and Major Depressive Disorder (MDD) conducted by oncology center Sunstone Therapies were published in the acclaimed JAMA Oncology.

CMPS

2 minute read

Australia’s Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions

By Lara Goldstein

February 7, 3:05 PM

As of July 1, psilocybin and MDMA (and related substances to both) can now be prescribed by authorized psychiatrists in Australia, which has become the

NUMIF

5 minute read

Psyched: Australia Legalizes Psychedelics Therapy, BC’s Decrim, State Bills, Millions For Trials & Clinics

By Lara Goldstein

February 6, 3:54 PM

Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically authorized psychiatrists to treat certain mental health conditions, such as post-traumatic stress disorder and psilocybin for treatment-resistant depression.

CSE:ORIG

Feed Tag: Psilocybin-Assisted Therapy

Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials

Trial Gives Cancer Patients 18 Months Of Robust Benefits After One Psilocybin Session

Canadian Psychedelics Company And Nonprofit Team Up To Accelerate Access And Product Launch

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism

Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder

Australia’s Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions

Psyched: Australia Legalizes Psychedelics Therapy, BC’s Decrim, State Bills, Millions For Trials & Clinics